3652, Vanderbilt Therapeutics (VT) CRS — Nashville, Tennessee

3652, Vanderbilt Therapeutics (VT) CRS is a clinical research site located in Nashville, Tennessee, United States 37204.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

3652, Vanderbilt Therapeutics (VT) CRS has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Acute HIV Infection.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 3652, Vanderbilt Therapeutics (VT) CRS?

3652, Vanderbilt Therapeutics (VT) CRS has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 3652, Vanderbilt Therapeutics (VT) CRS conducted?

3652, Vanderbilt Therapeutics (VT) CRS has 1 clinical trials on record, with 1 currently active. Their work covers Acute HIV Infection.

Is 3652, Vanderbilt Therapeutics (VT) CRS accredited by Crixeo Health?

3652, Vanderbilt Therapeutics (VT) CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 3652, Vanderbilt Therapeutics (VT) CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.